AI Is The New Electricity

Michael Ibara, Chief Data Officer, Elligo Health Research, discusses the history of mining healthcare data and using it to identify safety events, as well as the evolution of bringing EHR data closer to the clinical research worlds. Ibara also touches on the implications of AI—comparing its fundamental impact as “the new electricity”—and its potential uses for clinical trials, regulatory, and the ethics around large language models.

Michael Ibara, Chief Data Officer, Elligo Health Research, has more than 20 years of experience in clinical research and development. His interests include regulatory and policy implications for digital healthcare. Before joining Elligo, he was the Head of Digital Healthcare for the Clinical Data Interchange Standards Consortium. Michael also has experience as Head of Business Development Coordination and Innovation and also Head of Pharmacovigilance Innovation at Pfizer, where he worked for 15 years in various positions.

The editors of Applied Clinical Trials bring you the latest commercial insights to master the science of success. Podcast episodes examine current trends, key conferences, and critical topics in the bio/pharmaceutical industry.